NCT02292225 2023-02-27Duvelisib With Obinutuzumab in Patients With CLL/SLL Previously Treated With a BTKi (SYNCHRONY)SecuraBioPhase 1 Terminated3 enrolled
NCT03074825 2019-07-24Study of Chiauranib in Relapsed/Refractory Non-Hodgkin's LymphomaChipscreen Biosciences, Ltd.Phase 1 Terminated5 enrolled
NCT02598570 2017-02-06Study Evaluating Duvelisib in Japanese Subjects With Relapsed or Refractory LymphomaAbbViePhase 1 Completed7 enrolled